Pathfinders in Biopharma

著者： RBC Capital Markets
無料で聴く

  • サマリー

  • Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
    Copyright 2025 RBC Capital Markets
    続きを読む 一部表示

あらすじ・解説

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
Copyright 2025 RBC Capital Markets
個人ファイナンス 政治・政府 経済学
続きを読む 一部表示
エピソード
  • Uncertainty reigns, but opportunity persists for biotech’s 2025

    Uncertainty reigns, but opportunity persists for biotech’s 2025
    2025/02/07

    Universal wisdom had it that a Republican sweep in the U.S. election would favor biotech. Appointments to the new administration’s healthcare leadership make that far less certain. What effect will this and other factors have on the industry in 2025, and where are the breakthroughs likely to be found? Brian Abrahams, Head of Global Healthcare Research at RBC Capital Markets, looks ahead with in this episode of Pathfinders in Biotech.
    続きを読む 一部表示
    9 分
  • Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments

    Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments
    2024/11/22

    Innovation is surging in the U.S biotechnology sector, so why are investors still fearful about committing? Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, is joined by fund founders Craig Gordon, MD, CEO and CIO at GordonMD® Global Investments LP and Srini Akkaraju, MD, PhD, Managing Partner at Samsara BioCapital, to analyze the prospects for a full return of capital to the sector.
    続きを読む 一部表示
    23 分
  • Former Investor Who Chose Broadcasting Over Biotech ETFs

    Former Investor Who Chose Broadcasting Over Biotech ETFs
    2024/09/30

    Former biotech investor, Brad Loncar has pivoted his career from investing to reporting on the industry. Instead of serving the biotech bubble, he hopes to reach a wide audience with interest in science. Loncar explains why he switched careers and sets out his ambitions for his channel, Biotech TV.
    続きを読む 一部表示
    12 分
activate_buybox_copy_target_t1

Pathfinders in Biopharmaに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。